US Broker Ratings

Chevron Corporation (CVX) Stock Analysis: Evaluating a 9.79% Potential Upside Amid Robust Revenue Growth

Chevron Corporation (CVX), a titan in the integrated oil and gas industry, commands investor attention with its expansive operations that span the globe. From its headquarters..

Senseonics Holdings, Inc. (SENS) Stock Analysis: Exploring a 39.63% Potential Upside

Investors with a keen eye on the healthcare sector might find Senseonics Holdings, Inc. (NASDAQ: SENS) an intriguing proposition. As a commercial-stage medical technology company, Senseonics..

Viant Technology Inc. (DSP) Stock Analysis: Unpacking a 58% Upside Potential Amid Strong Buy Ratings

Viant Technology Inc. (NASDAQ: DSP) is currently garnering significant attention from investors, largely due to its promising position in the technology sector, specifically in the software-application..

Gossamer Bio, Inc. (GOSS) Stock Analysis: Unveiling a Potential 596% Upside

Gossamer Bio, Inc. (NASDAQ: GOSS), a clinical-stage biopharmaceutical company, is capturing investor interest with its staggering potential upside of 596.03%, according to analyst ratings. This San..

SoundHound AI, Inc. (SOUN) Investor Outlook: Analyzing the 108% Potential Upside for This AI Pioneer

SoundHound AI, Inc. (NASDAQ: SOUN) stands out in the competitive landscape of technology stocks with its unique focus on independent voice artificial intelligence solutions. Based in..

Tvardi Therapeutics, Inc. (TVRD) Stock Analysis: An Undervalued Gem with 640% Upside Potential

Tvardi Therapeutics, Inc. (NASDAQ: TVRD), a clinical-stage biopharmaceutical company, has been generating buzz among investors, thanks to its promising pipeline and eye-catching potential upside of 640%...

Nerdy Inc. (NRDY) Stock Analysis: Unpacking a 198% Potential Upside for Investors

Nerdy Inc. (NRDY), a technology company specializing in software applications, is garnering attention due to its significant potential upside. With a current market capitalization of $589.4..

Spok Holdings, Inc. (SPOK) Stock Analysis: Unpacking a High Dividend Yield in the Healthcare Sector

Spok Holdings, Inc. (NASDAQ: SPOK) is quietly making waves in the healthcare information services industry, boasting a remarkable dividend yield of 11.93%. With a market capitalization..

Benitec Biopharma Inc. (BNTC): 143% Potential Upside Ignites Investor Interest

Benitec Biopharma Inc. (NASDAQ: BNTC) may not be a household name, but for those tracking the biotechnology sector, it represents a compelling opportunity. With a market..

Yalla Group Limited (YALA) Stock Analysis: Exploring the 35% Upside Potential

Yalla Group Limited (YALA), a prominent player in the technology sector, is capturing investor attention with its notable potential upside of 35.57%. Headquartered in Dubai, UAE,..

Cytek Biosciences, Inc. (CTKB) Stock Analysis: Navigating Through a Challenging but Promising Healthcare Landscape

Cytek Biosciences, Inc. (NASDAQ: CTKB) stands at the forefront of the healthcare sector, specifically within the medical devices industry. Based in Fremont, California, the company is..

Alpha Teknova, Inc. (TKNO) Stock Analysis: Unraveling Growth Potential Amidst Healthcare Innovation

Investors eyeing opportunities in the healthcare sector might find Alpha Teknova, Inc. (TKNO) an intriguing candidate. As a key player in the Drug Manufacturers – Specialty..

Vanda Pharmaceuticals Inc. (VNDA) Stock Analysis: Unpacking the Potential 139% Upside

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA), a key player in the biotechnology sector, presents an intriguing investment opportunity for discerning investors. Despite the company’s current challenges, notably..

Phathom Pharmaceuticals (PHAT): A 180% Upside Potential Amid Strong Buy Ratings

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) is capturing significant attention from investors in the biotechnology sector. Specializing in the development and commercialization of treatments for gastrointestinal diseases,..

aTyr Pharma, Inc. (ATYR) Stock Analysis: Exploring an 842.95% Potential Upside

aTyr Pharma, Inc. (NASDAQ: ATYR), a clinical-stage biotechnology company, has caught the attention of investors with its impressive potential upside of 842.95%, according to analyst ratings...

Erasca, Inc. (ERAS) Stock Analysis: Unveiling a 64% Potential Upside in Biotechnology

Erasca, Inc. (NASDAQ: ERAS), a clinical-stage biotechnology company, is turning heads in the healthcare sector with its promising developments in precision oncology. With a focus on..

NANO-X IMAGING LTD (NNOX) Stock Analysis: Unveiling a 495% Potential Upside for Investors

Nano-X Imaging Ltd (NASDAQ: NNOX), a trailblazer in the medical devices industry, is making waves with its innovative approach to digital X-ray technology. Based in Petah..

TotalEnergies SE (TTE) Stock Analysis: Unpacking a 14.39% Upside Potential for Investors

TotalEnergies SE (TTE), a powerhouse in the integrated oil and gas industry, has caught the eye of investors with a notable 14.39% potential upside. This French-based..

Zhengye Biotechnology (ZYBT) Stock Analysis: Navigating Uncharted Waters in the Veterinary Vaccine Market

Zhengye Biotechnology Holding Limited (ZYBT), a niche player in the healthcare sector, has carved out a unique position in the drug manufacturing industry, specifically focusing on..

Varex Imaging Corporation (VREX): Investor Outlook on Medical Device Innovator with a 2.44% Potential Upside

Varex Imaging Corporation (NASDAQ: VREX) stands as a notable player in the healthcare sector, specifically within the medical devices industry. With a current market capitalization of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds